Navigation Links
New treatment for severe aortic stenosis shown to save lives, Stanford researchers say
Date:9/22/2010

he diseased valve, that was not a realistic option for the specific patients selected for this study, who were too sick or too old to undergo such an operation. For them, the standard of care is medical therapy.

At one year after randomization, 30.7 percent of patients who had received the percutaneous valve replacement had died compared with 50.7 percent of those who received standard medical therapy.

"The most impressive finding in the study is the 20 percent reduction in mortality," said William Fearon, MD, associate professor of cardiovascular medicine at Stanford, who also participated in the study. "This is very dramatic. The effect was so powerful that by just treating five people you can save one life. But beyond just the survival benefit, the improvement in the patients' quality of life based on their symptoms and their ability to exercise is dramatic."

Stanford enrolled more than 80 patients in the PARTNER study, of which 14 were these very sick patients. Jana Pausa, 76, of Atherton, Calif., who had both severe aortic stenosis and lung disease that made her unsuitable for open-heart surgery to replace the diseased heart valve, is one such patient.

"Getting dressed or anything was absolutely debilitating," said Pausa, who was randomized to have the device implanted a year and a half ago. "Before the surgery, I used a walker. Sleeping was difficult because I didn't feel like I could breathe. I had no energy. When I woke up out of surgery, I immediately felt the difference. I could breathe - for sure it saved my life."

Now she's walking and playing with her grandchildren and planning for her husband's 80th birthday party.

Many patients with severe aortic stenosis come into the hospital in a wheelchair, said Alan Yeung, MD, the Li Ka Shing Professor of Medicine and chief of Stanford's division of cardiovascular medicine, who was also involved in the study. "Nobody thinks they're going to walk out of the hos
'/>"/>

Contact: Tracie White
traciew@stanford.edu
650-723-7628
Stanford University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. University Hospitals Case Medical Center implements AutoLITT system for treatment of brain tumors
2. Investigational eye treatment: Corneal collagen crosslinking research study
3. Are we ready for medical treatment based on a patients racial and ethnic background?
4. Prostate cancer community calls for better early detection and treatment
5. Scott & White Healthcare to participate in international trial investigating lung cancer treatment
6. New study finds positive return on investment for states that invest in quit smoking treatments
7. Common Asthma Drug Could Speed MS Treatment
8. Gene discovery could yield treatments for nearsightedness
9. Promising treatment for metastatic melanoma fast tracked by FDA
10. Parents report a widely prescribed antibiotic is effective for fragile X treatment
11. Study finds more Americans bypassing their personal physician when immediate treatment required
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 2014 Super Saturday, the last Saturday ... as the busiest day in the 2014 holiday shopping ... Station had a steady pre-Christmas stream of customers, ready ... Saturday. , “I definitely intend to take advantage…of the ... resident who was enjoying The Grass Station’s holiday sale ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Give a ... season, the gift of health and vitality. , For ... its three top-selling anti-aging formulas in special Holiday Wellness ... rush delivery. , Each bottle contains cutting-edge, proven ... that don't work as well as we age. ...
(Date:12/22/2014)... December 22, 2014 Pasadena sleep ... consultations for sleep apnea. Drowsy drivers are 15 times ... who are well-rested, and some experts believe that sleep-deprived ... as intoxicated drivers. Unfortunately, millions of Americans may be ... Academy of Sleep Medicine, about 18 million Americans have ...
(Date:12/22/2014)... TheHardwareCity.com now stocks MagnoGrip Pro Utility Magnetic ... Customers of the large online tool shop enjoy a ... to their home or workplace with free shipping. , ... heavy duty magnets, which make work easier. The patented ... metal parts on the back of their hand, including ...
(Date:12/22/2014)... NAPW honors Michelle M. ... Year. Ms. Foley is recognized with this prestigious distinction ... organization of professional women in the country, spanning virtually ... Women is a powerfully vibrant networking community with over ... a nurse, I felt like I made a difference ...
Breaking Medicine News(10 mins):Health News:Customers at Colorado’s Grass Station Say They’re Enjoying the Experience of Legally Purchasing Marijuana this Year to Give as Christmas Presents to Friends and Family 2Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2Health News:Pasadena Dentist, Dr. Marine Martirosyan, Now Offers Consultations for Sleep Apnea 2Health News:MagnoGrip Pro Utility Magnetic Gloves on Sale at TheHardwareCity.com 2Health News:National Association of Professional Women Announces Michelle M. Foley, Vice President of Operations of OTTR Chronic Care Solutions, a 2014 Professional Woman of the Year 2
... Jan. 27 Hooper Holmes (Amex: HH ... as Senior Vice President, General Counsel and Corporate Secretary. ... of Hooper Holmes, Inc.Mr. Rosenblum has over 23 years ... including intellectual property, securities, contract, consumer and other class ...
... Net Product Sales Increased 9% Over 2007 to $765.3 ... 2010SAN DIEGO, Calif., Jan. 27 Amylin Pharmaceuticals, Inc. ... for the quarter and year ended December 31, 2008. ... the quarter ended December 31, 2008, which includes net ...
... Systems, Inc. (NASDAQ: MRCY ), a leading ... complex image, sensor, and signal processing applications, announced that ... sale of its wholly-owned subsidiaries, Visage Imaging(R), Inc. and ... Limited. The financial terms of the transaction were not ...
... to Public OpinionWASHINGTON, Jan. 27 Political considerations ... from President Obama,s huge economic stimulus package, despite ... their high level of public approval.A recent Lake ... Women Donors Network in early November 2008 around ...
... could help treat depression, other disorders, researchers say , , ... scientists say they,ve devised a potential new method ... the natural dynamics of the body,s "fight or flight" ... adrenal (HPA) axis, one of the body,s major control ...
... just watching symptoms leads to similar survival rates in ... Using the biomarker molecule known as brain natriuretic peptide ... heart failure did not improve the clinical outcome in ... been conflicting reports about the value of monitoring blood ...
Cached Medicine News:Health News:Hooper Holmes Names Mark Rosenblum Senior Vice President, General Counsel and Corporate Secretary 2Health News:Hooper Holmes Names Mark Rosenblum Senior Vice President, General Counsel and Corporate Secretary 3Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 2Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 3Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 4Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 5Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 6Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 7Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 8Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 9Health News:Amylin Pharmaceuticals Reports 2008 Financial Results 10Health News:Mercury Computer Systems Announces the Sale of Visage Imaging to Pro Medicus Limited 2Health News:Mercury Computer Systems Announces the Sale of Visage Imaging to Pro Medicus Limited 3Health News:Mercury Computer Systems Announces the Sale of Visage Imaging to Pro Medicus Limited 4Health News:Family Planning Again Becomes Political Football 2Health News:Family Planning Again Becomes Political Football 3Health News:Monitoring Protein Didn't Improve Heart Failure Outcomes 2Health News:Monitoring Protein Didn't Improve Heart Failure Outcomes 3
(Date:12/22/2014)... NEW YORK , Dec. 22, 2014 /PRNewswire/ ... developing novel therapies for the treatment of chronic ... subjects has been dosed in a pharmacokinetic and ... receptor antagonist for neuropathic pain. Racemic ... treatment of various pain states and substitution therapy ...
(Date:12/19/2014)... 2014 TODAY, AEGATE, the leader ... announced the appointment of Peter Fox as ... Channels and Partner Officer. Peter has served ... its acquisition by Oracle in 2011. Prior ... Geneva and subsequently Convergys, a world renowned ...
(Date:12/19/2014)... 2014  Advanced Medical Isotope Corporation ("AMIC") (OTCQB:  ... in the development of brachytherapy devices and medical ... that a Life Sciences Discovery Fund (LSDF) Proof ... AMIC is the commercialization partner.  The award was ... proposal titled "Optimized Injectable Radiogels for High-dose Therapy ...
Breaking Medicine Technology:Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 2Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 3Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 2Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 3
... Schering-Plough Corporation,(NYSE: SGP ) today reported that ... Phase II study of boceprevir, its investigational oral ... chronic,hepatitis C virus (HCV) genotype 1 were presented ... for the Study of the Liver (EASL). The,ongoing ...
... Into New Promising Drugs to Combat Hepatitis ... C ... Stem Cells of Potential Benefit in Liver Transplantation, ... At today,s sessions of the 43rd Annual Meeting of the European,Association for the ...
Cached Medicine Technology:Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 2Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 3Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 4Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 5Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 6Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 7Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 8Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 9Basic Science Discoveries Yield Progress in Hepatology 2Basic Science Discoveries Yield Progress in Hepatology 3Basic Science Discoveries Yield Progress in Hepatology 4
The Storz Protege is an anterior segment unit only....
The CV-12000 provides the surgeon with all the options to perform today's newest techniques....
Phaco-emulsification systems CV series...
The unprecedented power, flexibility and versatility of the Series 20000 Legacy have made it the world's leading phacoemulsifier....
Medicine Products: